Related Experiment Video
Updated: Aug 13, 2026

Rodent Working Heart Model for the Study of Myocardial Performance and Oxygen Consumption
Published on: August 16, 2016
[Catecholamines--therapeutic and adverse effects on the heart]
1Departement Geneeskundige Fisiologie en Biochemie, Universiteit van Stellenbosch, Parowvallei, KP.
Abstract:
Catecholamine activation enhances the inotropy of the heart by increasing the sarcolemmal influx of Ca2+. This increased influx is counteracted by an increased sarcolemmal efflux and sarcoplasmic reticulum uptake of Ca2+. Thus the intracellular milieu is protected against a gradual rise in Ca2+ concentration. However, under conditions of continuous, excessive catecholamine release, the heart's potential to remove Ca2+ from the cytosol might become exhausted. This might be caused by a Ca2+-dependent exhaustion of high-energy phosphates. As a result of this, Ca2+ overload of the myocytes and eventually a decrease in the pump function of the heart might occur. This paradox has implications for the clinical management of ischaemic heart disease.
Related Concept Videos
Adrenergic Agonists: Direct-Acting Agents
These agents can be classified...
Adrenergic Agonists: Therapeutic Classification
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Heart Failure Drugs: β-Blockers

